17:04 EDT Caribou Biosciences (CRBU) files $300M mixed securities shelf
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CRBU:
- Caribou Biosciences price target lowered to $9 from $11 at BofA
- Strategic Refocus and Upcoming Catalysts Support Buy Rating for Caribou Biosciences
- Caribou Biosciences price target lowered to $3 from $9 at H.C. Wainwright
- Strategic Restructuring and Focus on Oncology Drive Buy Rating for Caribou Biosciences
- Caribou reduces workforce by 32%, discontinues GALLOP and AMpLify trials